Redeye is positive about the acquisition of Rosetta Capital’s shares in the investment vehicle KDev ...
The trend of a healthy lifestyle enjoys a sustainably growing attraction across all age groups.
Flughafen Wien’s May traffic data were better than feared and support our positive stance on the sto...
LIMES signed a preliminary yet binding agreement to acquire the operating company of the “Villa Bocc...
Solwers estimates that its performance in H1 2026 has developed weaker than expected and withdraws i...
On 18 November 2025, Mendus entered into a loan facility with Fenja (of SEK 50m in total).
SynAct has reported top-line results from its Phase IIb ADVANCE study evaluating resomelagon in newl...
Director of M&A and Business Development, Sebastian Seppänen, has been appointed as interim CFO of R...
B&C raised its stake by 6.1pp to 63.4% via a € 15/share offer.
GFT’s quality banking IT franchise, AI-enabled project expansion and UK/smartshore margin levers rem...
We expect a Q2 characterised by an ongoing transition, including recently announced cost savings, wh...
The list of qualified suppliers for the large UK tactical communication tender was published today.
InCoax has announced a SEK 11.2m directed share issue alongside an expanded credit facility, further...
Redeye comments on Faron's updated BEXMAB data presented at EHA 2026, which demonstrated continued m...
Cicor announced this morning it is divesting its Tunisian production facility which will close in Ju...
Bittium announced a strengthening to its AI-based offering, building on its other recent announcemen...
Apotea är Sveriges ledande nätapotek med en dominant marknadsposition och fortsatt potential för til...
Redeye views the topline data as confirming a bell-shaped dose-response with resomelagon.
Systemair avslutar 2025/26 starkt med hög organisk tillväxt, förbättrad lönsamhet men svagare kvarta...
Freemelt’s investor update on June 2nd shed some light on the progress within the business verticals...
